Literature DB >> 29942201

Management of Recurrent Non-Muscle Invasive Bladder Cancer.

Marc A Bjurlin1.   

Abstract

Entities:  

Year:  2018        PMID： 29942201      PMCID： PMC6003303          DOI： 10.3909/riu0789

Source DB:  PubMed          Journal:  Rev Urol        ISSN： 1523-6161


× No keyword cloud information.
  5 in total

Review 1.  Systematic review and cumulative analysis of oncologic and functional outcomes after robot-assisted radical cystectomy.

Authors:  Bertram Yuh; Timothy Wilson; Bernie Bochner; Kevin Chan; Joan Palou; Arnulf Stenzl; Francesco Montorsi; George Thalmann; Khurshid Guru; James W F Catto; Peter N Wiklund; Giacomo Novara
Journal:  Eur Urol       Date:  2015-01-02       Impact factor: 20.096

2.  High-Risk of Adverse Pathologic Features in Patients With Clinical T1 High-Grade Bladder Cancer Undergoing Radical Cystectomy.

Authors:  Richard S Matulewicz; Brendan T Frainey; Daniel T Oberlin; Joshua J Meeks
Journal:  J Natl Compr Canc Netw       Date:  2016-10-31       Impact factor: 11.908

Review 3.  Bladder cancer.

Authors:  Ashish M Kamat; Noah M Hahn; Jason A Efstathiou; Seth P Lerner; Per-Uno Malmström; Woonyoung Choi; Charles C Guo; Yair Lotan; Wassim Kassouf
Journal:  Lancet       Date:  2016-06-23       Impact factor: 79.321

4.  First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study.

Authors:  Arjun V Balar; Daniel Castellano; Peter H O'Donnell; Petros Grivas; Jacqueline Vuky; Thomas Powles; Elizabeth R Plimack; Noah M Hahn; Ronald de Wit; Lei Pang; Mary J Savage; Rodolfo F Perini; Stephen M Keefe; Dean Bajorin; Joaquim Bellmunt
Journal:  Lancet Oncol       Date:  2017-09-26       Impact factor: 41.316

Review 5.  Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline.

Authors:  Sam S Chang; Stephen A Boorjian; Roger Chou; Peter E Clark; Siamak Daneshmand; Badrinath R Konety; Raj Pruthi; Diane Z Quale; Chad R Ritch; John D Seigne; Eila Curlee Skinner; Norm D Smith; James M McKiernan
Journal:  J Urol       Date:  2016-06-16       Impact factor: 7.450
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.